Minerva Neurosciences (NERV) Accumulated Expenses (2013 - 2026)

Minerva Neurosciences (NERV) has 14 years of Accumulated Expenses data on file, last reported at $355729.0 in Q1 2026.

• Quarterly Accumulated Expenses rose 481.27% year-over-year to $355729.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $355729.0 (up 481.27% YoY) and the FY2025 annual result came in at $1.7 million, up 34.32% from the prior year.
• Accumulated Expenses retreated to $355729.0 in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $3.9 million in Q3 2024 to a low of $47984.0 in Q1 2022.
• A 5-year average of $928849.3 and a median of $727302.0 in 2024 frame the typical range for Accumulated Expenses.
• Annual changes were most pronounced in 2023 — Accumulated Expenses plunged 92.98% — and 2024, when it surged 4797.56%.
• Tracing NERV's Accumulated Expenses over 5 years: stood at $407909.0 in 2022, then surged by 276.33% to $1.5 million in 2023, then retreated by 19.94% to $1.2 million in 2024, then jumped by 34.32% to $1.7 million in 2025, then plunged by 78.45% to $355729.0 in 2026.
• The last three Accumulated Expenses figures came in at $355729.0 (Q1 2026), $1.7 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.